Therefore, these results suggest that in PC-3 prostate cancer cells, low concentrations of hemin may exhibit ANO1-dependent anticancer effects, and high concentrations of hemin may exhibit additional anticancer effects via other pathways such as increasing HO-1 expression. The gene discussed is HMOX1; the disease is Familial prostate cancer.